16
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Large Intravenous Bilirubin Loads Increase the Cytotoxicity of Bile and Lower the Resistance of the Canalicular Membrane to Cytotoxic Injury and Cause Cholestasis in Pigs

Pages 201-208 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

H.-U. Marschall, M. Trauner & F. Lammert. (2003) Jaundice. Scandinavian Journal of Gastroenterology 38:3, pages 233-234.
Read now

Articles from other publishers (3)

Mina Lee, Myungjin Jang, Jayun Jo, Byungchul Yu, Giljae Lee, Jungnam Lee, Seunghwan Lee, Yangbin Jeon & Kangkook Choi. (2023) Hyperbilirubinemia as a Risk Factor for Mortality and Morbidity in Trauma Patients. Journal of Clinical Medicine 12:13, pages 4203.
Crossref
Douwe Dekker, Mirrin J. Dorresteijn, Marieke E. B. Welzen, Simone Timman, Peter Pickkers, David M. Burger, Paul Smits, Frank A. D. T. G. Wagener & Frans G. M. Russel. (2018) Parenteral bilirubin in healthy volunteers: a reintroduction in translational research. British Journal of Clinical Pharmacology 84:2, pages 268-279.
Crossref
John M. Seubert, Christopher J. Sinal & John R. Bend. (2002) Acute sodium arsenite administration induces pulmonary CYP1A1 mRNA, protein and activity in the rat. Journal of Biochemical and Molecular Toxicology 16:2, pages 84-95.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.